# Filing Detail

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-17-011029
Filing Date
2017-02-24
Accepted
2017-02-24 17:24:48
Documents
81
Period of Report
2016-12-31

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | FORM 20-F | v460184_20f.htm | 20-F | 1245677
2 | EXHIBIT 12.1 | v460184_ex12-1.htm | EX-12.1 | 8215
3 | EXHIBIT 12.2 | v460184_ex12-2.htm | EX-12.2 | 8190
4 | EXHIBIT 13.1 | v460184_ex13-1.htm | EX-13.1 | 4465
5 | EXHIBIT 13.2 | v460184_ex13-2.htm | EX-13.2 | 4551
6 | EXHIBIT 15.1 | v460184_ex15-1.htm | EX-15.1 | 3846
7 | GRAPHIC | logo_20f.jpg | GRAPHIC | 2077
8 | GRAPHIC | pg04img01_20f.jpg | GRAPHIC | 10449
9 | GRAPHIC | pg40img01_20f.jpg | GRAPHIC | 74125
10 | GRAPHIC | pg41img01_20f.jpg | GRAPHIC | 119160
| Complete submission text file | 0001144204-17-011029.txt |  | 5526743

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
11 | XBRL INSTANCE DOCUMENT | orpn-20161231.xml | EX-101.INS | 1116457
12 | XBRL TAXONOMY EXTENSION SCHEMA | orpn-20161231.xsd | EX-101.SCH | 42487
13 | XBRL TAXONOMY EXTENSION CALCULATION LINKBASE | orpn-20161231_cal.xml | EX-101.CAL | 41257
14 | XBRL TAXONOMY EXTENSION DEFINITION LINKBASE | orpn-20161231_def.xml | EX-101.DEF | 235959
15 | XBRL TAXONOMY EXTENSION LABEL LINKBASE | orpn-20161231_lab.xml | EX-101.LAB | 279778
16 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE | orpn-20161231_pre.xml | EX-101.PRE | 292230

Mailing Address 37 DEREH MENACHEM BEGIN ST. 15TH FLOOR TEL AVIV L3 6522042
Business Address 37 DEREH MENACHEM BEGIN ST. 15TH FLOOR TEL AVIV L3 6522042 972 (0) 3 7326616
Bioblast Pharma Ltd. (Filer) CIK: 0001596812 (see all company filings)

EIN.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 20-F | Act: 34 | File No.: 001-36578 | Film No.: 17638652
SIC: 2834 Pharmaceutical Preparations